TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T95399	Myophosphorylase	B27XQE	alpha-D-Glucose	Investigative	79025	C6H12O6	180.16	C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O	Ki = 1700000 nM	Non binder
T95399	Myophosphorylase	B2FUT9	(2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol	Investigative	13908996	C42H72O36	1153	C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](OC([C@@H]([C@H]7O)O)O)CO)CO)CO)CO)CO)CO)O)O)O)O	Ki = 1000000 nM	Non binder
T95399	Myophosphorylase	BHN84W	5-Ethynyl-1-(beta-D-Glucopyranosyl)pyrimidine-2,4(1h,3h)-Dione	Investigative	57519731	C12H14N2O7	298.25	C#CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O	IC50 = 291400 nM	Non binder
T95399	Myophosphorylase	BJEC27	4-[2-(3-Carboxy-benzoylamino)-phenoxy]-phthalic acid	Investigative	11200978	C22H15NO8	421.4	C1=CC=C(C(=C1)NC(=O)C2=CC(=CC=C2)C(=O)O)OC3=CC(=C(C=C3)C(=O)O)C(=O)O	IC50 > 200000 nM	Non binder